PXMP2 inhibits tumor stemness and immune infiltration in hepatocellular carcinoma based on stemness risk.
- Published in:
- Discover Oncology, 2025, v. 16, n. 1, p. 1, doi. 10.1007/s12672-025-02976-4
- By:
- Publication type:
- Article
Works by Ye, Dingde
Results: 5
1
2
A pan-cancer analysis of the prognostic and immunological roles of matrix metalloprotease-1 (MMP1) in human tumors.
- Published in:
- Frontiers in Oncology, 2023, v. 13, p. 01, doi. 10.3389/fonc.2022.1089550
- By:
- Publication type:
- Article
3
Identification of lncRNA biomarkers in hepatocellular carcinoma by comprehensive analysis of the lncRNA-mediated ceRNA network.
- Published in:
- Frontiers in Genetics, 2022, v. 13, p. 1, doi. 10.3389/fgene.2022.832952
- By:
- Publication type:
- Article
4
A New Risk Score Based on Eight Hepatocellular Carcinoma- Immune Gene Expression Can Predict the Prognosis of the Patients.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.766072
- By:
- Publication type:
- Article
5
A New Clinical Nomogram From the TCGA Database to Predict the Prognosis of Hepatocellular Carcinoma.
- Published in:
- Frontiers in Oncology, 2021, v. 12, p. 1, doi. 10.3389/fonc.2021.698980
- By:
- Publication type:
- Article